$PRLD 8-K SEC Filings

Filed On	Filing
10 Sep 2026	8-K: Regulation FD Disclosure Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader
11 Aug 2026	8-K: Results of Operations and Financial Condition
10 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
12 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
21 Apr 2026	8-K: Entry into a Material Definitive Agreement; Other Events
20 Apr 2026	8-K: Regulation FD Disclosure; Other Events
15 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Mar 2026	8-K: Other Events
10 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
03 Feb 2026	8-K: Regulation FD Disclosure
09 Jan 2026	8-K: Regulation FD Disclosure
12 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
04 Nov 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
17 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
19 Sep 2025	8-K: Other Events
14 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
13 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
06 May 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
25 Apr 2025	8-K: Other Events
28 Mar 2025	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

Comments